#160: EMSP Conference 2026 in Berlin: A Must-Attend Event for the MS Community
The EMSP Conference 2026 is one of Europe’s leading events for MS, NMOSD, and MOGAD. Join online for free and gain valuable insights from experts and patient advocates.
#154: How Pharmacovigilance Keeps MS Therapies Safe: From Drug Development to Real-World Monitoring (with Dr. Nora Möhn)
Multiple sclerosis treatments have advanced fast—but safety monitoring matters more than ever. In this interview, Dr. Nora Möhn explains pharmacovigilance step by step: from clinical trial phases and approval to post-marketing surveillance and reporting systems (EU/US/UK/Canada). You’ll learn how neurologists weigh benefits and risks, and how you can discuss side effects confidently.
#148: Recognizing silent progression in MS with Prof. Dr. Heinz Wiendl
Silent progression in MS can occur even without relapses and often remains unnoticed for a long time. In this interview, Prof. Dr. Heinz Wiendl explains how patients and clinicians can recognize subtle changes early, why invisible symptoms matter and what recent research and new therapeutic approaches mean for the future.
